Clinical Updates Week of March 3, 2012

Oncology link roundup for the week of March 3, 2012:

A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis 

http://www.nejm.org/doi/full/10.1056/NEJMoa1110557

http://www.newswise.com/articles/drug-improves-survival-and-quality-of-life-for-people-with-myelofibrosis

Breast conserving therapy versus mastectomy for stage I—II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial

http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(12)70042-6/abstract

Very long-term follow-up results of imatinib mesylate therapy in chronic phase chronic myeloid leukemia after failure of interferon alpha therapy†

http://onlinelibrary.wiley.com/doi/10.1002/cncr.26568/full

FDA Acts to Curb Doxorubicin, Methotrexate Shortages

http://www.oncologystat.com/news/FDA_Acts_to_Curb_Doxorubicin__Methotrexate_Shortages_US.html

Advertisements

One comment

  1. dating sites

    dating sites
    Do you mind if I quote a few of your posts providing I provide credit and sources back to your weblog? My blog site is in the exact same area of interest as yours and my visitors would definitely benefit from a lot of the information you provide here. Please let me know if this ok with you. Thanks!

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s